Literature DB >> 20503064

Angiogenesis as a predictor of recurrence in meningiomas.

Valeria Barresi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20503064     DOI： 10.1007/s11060-010-0232-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.

Authors:  Valeria Barresi; Giovanni Tuccari
Journal:  Neuropathology       Date:  2010-10       Impact factor: 1.906

3.  Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.

Authors:  K Lamszus; U Lengler; N O Schmidt; D Stavrou; S Ergün; M Westphal
Journal:  Neurosurgery       Date:  2000-04       Impact factor: 4.654

4.  Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density.

Authors:  Valeria Barresi; Enrica Vitarelli; Serenella Cerasoli
Journal:  Virchows Arch       Date:  2009-03-19       Impact factor: 4.064

5.  Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.

Authors:  Valeria Barresi; Serenella Cerasoli; Enrica Vitarelli; Giovanni Tuccari
Journal:  Acta Neuropathol       Date:  2007-06-27       Impact factor: 17.088

6.  The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

7.  Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.

Authors:  F J Burrows; E J Derbyshire; P L Tazzari; P Amlot; A F Gazdar; S W King; M Letarte; E S Vitetta; P E Thorpe
Journal:  Clin Cancer Res       Date:  1995-12       Impact factor: 12.531

8.  Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.

Authors:  Helga B Salvesen; Mine G Gulluoglu; Ingunn Stefansson; Lars A Akslen
Journal:  APMIS       Date:  2003-11       Impact factor: 3.205

9.  Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.

Authors:  S Pistolesi; L Boldrini; S Gisfredi; K De Ieso; T Camacci; M Caniglia; G Lupi; P Leocata; F Basolo; R Pingitore; G Parenti; G Fontanini
Journal:  Neuropathol Appl Neurobiol       Date:  2004-04       Impact factor: 8.090

10.  Evaluation of neo-angiogenesis in a case of chordoid meningioma.

Authors:  Valeria Barresi; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2009-06-26       Impact factor: 4.130
  10 in total
  2 in total

1.  A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

Authors:  Jeffrey J Raizer; Sean A Grimm; Alfred Rademaker; James P Chandler; Kenji Muro; Irene Helenowski; Laurie Rice; Katie McCarthy; Sandra K Johnston; Maciej M Mrugala; Marc Chamberlain
Journal:  J Neurooncol       Date:  2014-01-22       Impact factor: 4.130

2.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.